Zobrazeno 1 - 10
of 34
pro vyhledávání: '"MH Haugen"'
Autor:
MH Haugen, OC Lindgjærde, M Krohn, W Zhao, EM Lindholm, L Silwal-Pandit, E Borgen, Ø Garred, A Fangberget, MM Holmen, E Schlichting, H Skjerven, S Lundgren, E Wist, B Naume, GM Mælandsmo, Y Lu, A-L Børresen-Dale, GB Mills, O Engebråten
Publikováno v:
Cancer Research. 77:P6-13
BACKGROUND: Patients with HER2 negative primary tumors of ≥25 mm were treated with neoadjuvant chemotherapy (4 x FEC100 + 12 weeks of taxane-based therapy) and randomized (1:1) to receive bevacizumab or not. Mammography, ultrasound and MR imaging w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::973c3419775ceceb3c0fe346f11746c7
https://doi.org/10.1158/1538-7445.sabcs16-p6-13-01
https://doi.org/10.1158/1538-7445.sabcs16-p6-13-01
Autor:
Egeland EV; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. e.v.egeland@ous-research.no., Seip K; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Skourti E; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway., Øy GF; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Pettersen SJ; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Pandya AD; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Dahle MA; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway., Kristian A; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Nakken S; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Centre for Bioinformatics, Department of Informatics, University of Oslo, Oslo, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Insitute for Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway-University of Tromsø, Tromsø, Norway., Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Publikováno v:
British journal of cancer [Br J Cancer] 2024 Nov; Vol. 131 (10), pp. 1656-1667. Date of Electronic Publication: 2024 Oct 10.
Autor:
Fleischer T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ankill J; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Silwal-Pandit L; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Hedenfalk I; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden., Hatschek T; Breast Cancer Center, Karolinska University Hospital, Stockholm, Sweden.; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Tost J; Laboratory for Epigenetics and Environment, Centre National de Recherche en Génomique Humaine, CEA - Institut de Biologie François Jacob, Université Paris Saclay, Evry, France., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway., Kristensen VN; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Aug; Vol. 18 (8), pp. 2042-2059. Date of Electronic Publication: 2024 Apr 26.
Autor:
Haugen MH; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., von der Lippe Gythfeldt H; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway., Egeland EV; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Svartdal Normann L; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway., Pandya AD; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Vedin LL; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Juell S; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Tenstad E; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Øy GF; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Kristian A; Department of Tumor Biology, Oslo University Hospital Oslo, Norway., Marangoni E; Translational Research Department, Institut Curie, PSL Research University, Paris, France., Sørlie T; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway., Steffensen K; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Maelandsmo GM; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Medical Biology, Faculty of Health Sciences, The Arctic University of Norway-University of Tromsø, Norway., Engebraaten O; Department of Tumor Biology, Oslo University Hospital Oslo, Norway.; Department of Oncology, Oslo University Hospital, Norway.; Insitute for Clinical Medicine, University of Oslo, Norway.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Oct; Vol. 17 (10), pp. 2041-2055. Date of Electronic Publication: 2023 Jun 30.
Autor:
Nygaard V; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Ree AH; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Akershus University Hospital, Lørenskog, Norway., Dagenborg VJ; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Børresen-Dale AL; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Edwin B; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.; The Intervention Center, Oslo University Hospital, Oslo, Norway., Fretland ÅA; Department of Hepato-Pancreato-Biliary Surgery, Oslo University Hospital, Oslo, Norway.; The Intervention Center, Oslo University Hospital, Oslo, Norway., Grzyb K; Department of Pathology, Oslo University Hospital, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway., Flatmark K; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway.
Publikováno v:
Cancer research communications [Cancer Res Commun] 2023 Feb 09; Vol. 3 (2), pp. 235-244. Date of Electronic Publication: 2023 Feb 09 (Print Publication: 2023).
Autor:
Normann LS; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Hongisto V; Division of Toxicology, Misvik Biology, Turku, Finland., Aure MR; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Leivonen SK; Applied Tumor Genomics Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland., Kristensen VN; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway., Tahiri A; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Sahlberg KK; Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway.
Publikováno v:
PloS one [PLoS One] 2023 Jan 27; Vol. 18 (1), pp. e0280507. Date of Electronic Publication: 2023 Jan 27 (Print Publication: 2023).
Autor:
Nyakas M; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway.; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Fleten KG; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway., Engedal N; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway., Sveen C; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway., Farstad IN; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Pathology, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway., Flørenes VA; Department of Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Prasmickaite L; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway. g.m.malandsmo@ous-research.no.; Department of Medical Biology, Faculty of Health Sciences, UiT/The Arctic University of Norway, Tromsø, Norway. g.m.malandsmo@ous-research.no., Seip K; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Ullernchausseen 70, 0379, Oslo, Norway. kotryna.seip@rr-research.no.
Publikováno v:
Scientific reports [Sci Rep] 2022 Mar 24; Vol. 12 (1), pp. 5076. Date of Electronic Publication: 2022 Mar 24.
Autor:
Normann LS; Department of Research and Innovation, Vestre Viken Hospital Trust, P.O. Box 800, 3004, Drammen, Norway.; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Aure MR; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Leivonen SK; Applied Tumor Genomics Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway., Hongisto V; Division of Toxicology, Misvik Biology, Turku, Finland., Kristensen VN; Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Division of Medicine, Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital, Lørenskog, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, UiT-The Arctic University of Norway, Tromsø, Norway., Sahlberg KK; Department of Research and Innovation, Vestre Viken Hospital Trust, P.O. Box 800, 3004, Drammen, Norway. Kristine.Sahlberg@vestreviken.no.; Department of Tumor Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. Kristine.Sahlberg@vestreviken.no.
Publikováno v:
Scientific reports [Sci Rep] 2021 May 25; Vol. 11 (1), pp. 10893. Date of Electronic Publication: 2021 May 25.
Autor:
Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Lingjærde OC; Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Department of Informatics-Biomedical Informatics, University of Oslo, Oslo, Norway.; K.G. Jebsen-Centre for B Cell Malignancies, Institute for Clinical Medicine, University of Oslo, Oslo, Norway., Hedenfalk I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden., Garred Ø; Division of Laboratory Medicine-Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Borgen E; Division of Laboratory Medicine-Pathology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Loman N; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Lund, Sweden.; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Skåne, Sweden., Hatschek T; Department of Oncology-Pathology, Karolinska University Hospital, Stockholm, Sweden., Børresen-Dale AL; Department of Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway., Naume B; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Mills GB; Department of Cell, Developmental and Cancer Biology, School of Medicine, Oregon Health Science University, Portland, OR., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute for Medical Biology, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø, Norway., Engebraaten O; Department of Tumor Biology, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.; Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
Publikováno v:
JCO precision oncology [JCO Precis Oncol] 2021 Jan 28; Vol. 5. Date of Electronic Publication: 2021 Jan 28 (Print Publication: 2021).
Autor:
Halvorsen AR; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway., Haugen MH; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway., Öjlert ÅK; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway., Lund-Iversen M; Department of Pathology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway., Jørgensen L; Department of Cardiothoracic Surgery, Oslo University Hospital-Rikshospitalet, Oslo, Norway., Solberg S; Department of Cardiothoracic Surgery, Oslo University Hospital-Rikshospitalet, Oslo, Norway., Mælandsmo GM; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Faculty of Health Sciences, Institute of Medical Biology, UiT-Arctic University of Norway, Tromso, Norway., Brustugun OT; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Section of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Helland Å; Department of Cancer Genetics, Institute for Cancer Research, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.; Department of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Oncology, Oslo University Hospital-Radiumhospitalet, Oslo, Norway.
Publikováno v:
Frontiers in oncology [Front Oncol] 2020 Nov 25; Vol. 10, pp. 590755. Date of Electronic Publication: 2020 Nov 25 (Print Publication: 2020).